Abstract:A series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones were synthesized and their anti-HIV-1 activities were evaluated. Most of these compounds were highly active against wild-type (WT) HIV-1 strain (IIIB) with EC50 values in the range of 0.0038-0.4759 mmol/L. Among those compounds, I-11 had an EC50 value of 3.8 nmol/L and SI (selectivity index) of up to 25,468 indicating excellent activity against WT HIV-1. In vitro anti-HIV-1 activity and resistance profile studies suggested that compounds I-11 and I-12 displayed potential anti-HIV-1 activity against laboratory adapted strains and primary isolated strains including different subtypes and tropism strains (EC(50)s range from 4.3 to 63.6 nmol/L and 18.9-219.3 nmol/L, respectively). On the other hand, it was observed that those two compounds were less effective with EC50 values of 2.77 and 4.87 mmol/L for HIV-1A(17) (K103N + Y181C). The activity against reverse transcriptase (RT) was also evaluated for those compounds. Both I-11 and I-12 obtained sub-micromolar IC50 values showing their potential in RT inhibition. The pharmacokinetics examination in rats indicated that compound I-11 has acceptable pharmacokinetic properties and bioavailability. Preliminary structure-activity relationships and molecular modeling studies were also discussed. (C) 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.

Microwave-assisted Combinatorial Synthesis of 2-Alkyl-2-(n-arylsulfonylindol- 3-Yl)-3-n-acyl-5-aryl-1,3,4-oxadiazolines As Anti-Hiv-1 Agents.

Microwave Assisted Synthesis and Anti-HIV-RT Activity of Diaryl Benzo[1,3]thiazin-4-ones

Design, Microwave-Assisted Synthesis and HIV-RT Inhibitory Activity of 2-(2,6-Dihalophenyl)-3-(4,6-dimethyl-5-(un)substituted-pyrimidin-2-yl)thiazolidin-4-ones

Microwave-assisted Synthesis of Dinucleoside Analogues Containing a Thiazolidin-4-one Linkage Via One-Pot Tandem Staudinger/aza-Wittig/cyclization.

Microwave-Assisted Synthesis and Bioactivity of Novel 2,2,4,5-Tetrasubstituted 3-Dichloroacetyl-1,3-oxazolidines

Synthesis of New 2-(N-arylsulfonylindol-3-yl)-3-aryl-1,3-thiazolidin-4-ones As Hiv-1 Inhibitors in Vitro

Design, Synthesis And Anti-Hiv-Reverse Transcriptase Activity Of Novel Diaryl Thiazolindin-4-One Derivatives Possessing Amide Linkage On N-3 Position

Rapid Synthesis and Antiviral Activity of (Quinazolin-4-ylamino)methyl-phosphonates Through Microwave Irradiation

Microwave-assisted Efficient Synthesis of Glucose-Based 3-Acetyl-5-alkyl-2,3-dihydro-1,3,4-oxadiazole Derivatives Catalyzed by Sodium Acetate.

Synthesis and Biological Activity of Novel 5′-Arylamino-nucleosides by Microwave-Assisted One-Pot Tandem Staudinger/aza-Wittig/reduction

Synthesis and Anti-Hiv-1 Activity of S-Dihydro(Alkyloxy)Benzyloxypyrimidine Derivatives

Synthesis and Biological Evaluation of Novel N-[3-(4-phenylpip-erazin-1-yl)-propyl]-carboxamide Derivatives

Design and Synthesis of Novel N-Arylsulfonyl-3-(2-yl-ethanone)-6-methylindole Derivatives As Inhibitors of HIV-1 Replication.

Synthesis and Biological Evaluation of a Series of 2-(((5-akly/aryl-1h-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3h)-ones As Potential HIV-1 Inhibitors.

Microwave-assisted efficient and convenient synthesis of 2,4(1H,3H)-quinazolinediones and 2-thioxoquinazolines.

Synthesis, Characterization and Bioactivities of the New 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines

Synthesis and Anti-Hiv Activity of Novel 2,4-Disubstituted-7-methyl-1,1,3-trioxo-2h,4h-pyrazolo[4,5-e][1,2,4]thiadiazine Derivatives

Synthesis and anti-HIV activity of 4-(naphthalen-1-yl)-1,2,5-thiadiazol-3-hydroxyl derivatives.

One-Pot Microwave-Assisted Synthesis of Novel Substituted N-Dichloroacetyl-4,5-dimethyl-1,3-oxazolidines

Microwave-Assisted Syntehsis of 2-Substituted 1H-Benzo[d]imidazoles and Their Antifungal Activities in Vitro

Synthesis and Biological Evaluation of Novel Hydroxylphenethyl-S-DACOs As High Active Anti-HIV Agents